Laser biofabrication of 3D multicellular tissue with perfusible vascular network
This project aims to revolutionize organ regeneration by developing a 3D vascular system using advanced bioprinting techniques to enable effective perfusion in tissue constructs.
Projectdetails
Introduction
Building 3D vascularised organs remains the major unsolved challenge to be overcome in biofabrication and tissue engineering. Establishing blood vessels capable of efficient transport of gas, nutrients, and metabolites to and from cells is a prerequisite for the survival of tissue constructs, both in vitro and when transplanted in vivo.
Complexity of Vascular Structures
High resolution multi-scale constructs are necessary to replicate the complexity of functional vascular perfusion from large scale arteries and veins to micron scale arterioles, venules, and capillaries.
Methodology
Using a unique combination of advanced laser bioprinting with two-photon polymerisation technique, a full vascular system may be generated by exploring different approaches, including:
- Scaffold-based
- Scaffold-free
- Sacrificial
- Hybrid
These methods aim to generate a complex vasculature with functional layers and extracellular matrix.
Research Gaps
The connection of artery and vein with engineered vascular trees, including capillaries, has received little research attention despite the crucial requirement to reliably connect perfusion inlets and outlets to a pulsatile flow system.
Importance of Perfusion
This connection is essential not only to perfuse tissue but also to stimulate and control the maturation of engineered tissue, enabling it to reach the conditions required to function with realistic biophysical characteristics of thick tissue outside of a closed incubation chamber.
Breakthrough Potential
Computer-controlled generation of a 3D vascular capillary tree and achieving its perfusion in centimetre scale cardiac and skin tissue constructs using the developed biofabrication methodologies will represent a seminal breakthrough in organ regeneration. This advancement is expected to have widespread long-term impacts across the field of regenerative medicine.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.499.539 |
Totale projectbegroting | € 2.499.539 |
Tijdlijn
Startdatum | 1-10-2022 |
Einddatum | 30-9-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVERpenvoerder
- LASER NANOFAB GMBH
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughputHEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments. | ERC Consolid... | € 2.969.219 | 2022 | Details |
Holographic Optical Tweezing Bioprinting (HOTB): Towards precise manipulation of cells for artificial multi-scaled vascularized tissues/organ printing.The HOT-BIOPRINTING project aims to revolutionize tissue engineering by developing a holographic optical tweezing bioprinter for high-resolution, automated 3D bioprinting of complex, vascularized tissues. | ERC Consolid... | € 1.965.525 | 2024 | Details |
4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogelsmorphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth. | ERC Starting... | € 1.499.906 | 2023 | Details |
Surgical optogenetic bioprinting of engineered cardiac muscleLIGHTHEART aims to revolutionize heart failure treatment by developing a surgical bioprinting tool that uses optogenetics to create engineered cardiac muscle directly at the patient's heart. | ERC Starting... | € 1.499.705 | 2023 | Details |
Computationally and experimentallY BioEngineeRing the next generation of Growing HEARTsG-CYBERHEART aims to develop innovative experimental and computational methods for creating adaptable bioengineered hearts to improve treatment for congenital heart disease. | ERC Starting... | € 1.497.351 | 2022 | Details |
3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughput
HEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments.
Holographic Optical Tweezing Bioprinting (HOTB): Towards precise manipulation of cells for artificial multi-scaled vascularized tissues/organ printing.
The HOT-BIOPRINTING project aims to revolutionize tissue engineering by developing a holographic optical tweezing bioprinter for high-resolution, automated 3D bioprinting of complex, vascularized tissues.
4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels
morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.
Surgical optogenetic bioprinting of engineered cardiac muscle
LIGHTHEART aims to revolutionize heart failure treatment by developing a surgical bioprinting tool that uses optogenetics to create engineered cardiac muscle directly at the patient's heart.
Computationally and experimentallY BioEngineeRing the next generation of Growing HEARTs
G-CYBERHEART aims to develop innovative experimental and computational methods for creating adaptable bioengineered hearts to improve treatment for congenital heart disease.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Prefabricated Mature Blood Vessels and Tools for Vascularized 3D Cell CultureThe Vasc-on-Demand project aims to develop three innovative products for easy generation of vascularized 3D tissues, enhancing research and drug testing while reducing reliance on animal trials. | EIC Transition | € 2.488.750 | 2024 | Details |
High-throughput ultrasound-based volumetric 3D printing for tissue engineeringSONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research. | EIC Pathfinder | € 2.999.625 | 2025 | Details |
building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgansTHOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants. | EIC Pathfinder | € 3.994.150 | 2023 | Details |
Engineering a living human Mini-heart and a swimming Bio-robotThe project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease. | EIC Pathfinder | € 4.475.946 | 2022 | Details |
3D Printing of Ultra-fideLity tissues using Space for anti-ageing solutions on EarthThe project aims to develop a novel bioprinting technology in microgravity to create advanced cardiac models for studying ageing and drug efficacy, enhancing biofabrication and space research. | EIC Pathfinder | € 4.597.578 | 2023 | Details |
Prefabricated Mature Blood Vessels and Tools for Vascularized 3D Cell Culture
The Vasc-on-Demand project aims to develop three innovative products for easy generation of vascularized 3D tissues, enhancing research and drug testing while reducing reliance on animal trials.
High-throughput ultrasound-based volumetric 3D printing for tissue engineering
SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.
building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgans
THOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants.
Engineering a living human Mini-heart and a swimming Bio-robot
The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.
3D Printing of Ultra-fideLity tissues using Space for anti-ageing solutions on Earth
The project aims to develop a novel bioprinting technology in microgravity to create advanced cardiac models for studying ageing and drug efficacy, enhancing biofabrication and space research.